Home › Products › Oncology › Hormoclib 75mg Capsule

Hormoclib 75mg Capsule

Salt Composition: PALBOCICLIB

₹3516.00₹16770.00

Inclusive of all taxes

Hormoclib 75mg Capsule

Categories: Oncology

Conditions: Anti Cancer

Product Introduction

Hormoclib 75mg Capsule contains Palbociclib, a targeted anticancer medication used to treat certain types of advanced breast cancer. Palbociclib belongs to the class of medicines known as cyclin-dependent kinase (CDK) 4/6 inhibitors, which work by blocking specific proteins responsible for the growth and division of cancer cells. By slowing the multiplication of cancer cells, Hormoclib 75mg Capsule helps delay disease progression and supports better treatment outcomes.

Hormoclib 75mg Capsule is primarily prescribed for the treatment of hormone receptor (HR)-positive, HER2-negative advanced or metastatic breast cancer. It is generally used in combination with hormone therapy rather than as a standalone treatment, enhancing the effectiveness of treatment and helping to control cancer for a longer period.Patients should consult their oncologist to determine whether Hormoclib 75mg Capsule is the most suitable treatment option for their specific medical condition.

Uses

Treatment of hormone receptor (HR)-positive, human epidermal growth factor 2 (HER2)-negative advanced or metastatic breast cancer.

How it works

Hormoclib 75mg Capsule works by blocking the protein called cyclin-dependent kinases 4 and 6, which are vital for the division and growth of cells. By blocking these proteins, this medication slows the growth and prevents the cancer cells from spreading.

How to Use

Take Hormoclib 75mg Capsule exactly as prescribed by your doctor. Take this medication once a day at the same time with food. Swallow this capsule as a whole with a glass of water. Avoid crushing, breaking, or chewing the capsule.

Side Effects

Side effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them. Hormoclib 75mg side effects include Serious: Blood disorder (fever, chills, shortness of breath, weakness, bleeding, or bruising) Lung inflammation (chest pain, dry cough, or difficulty breathing) Common: Tiredness Hair loss Dry skin, rash Infections Low blood cell counts Decreased of appetite Nausea, vomiting Diarrhea Swelling of lips and mouth Changes in taste Nose bleed Dry eye, blurred vision, increased tearing

Expert Tips

Avoid grapefruit, grapefruit juice, and products containing St. John’s wort during Hormoclib 75mg Capsule treatment. Use effective birth control: For females: during treatment and for at least 3 weeks after the final dose. For males: during treatment and for at least 14 weeks after the final dose. This medicine may reduce fertility — discuss any concerns with your doctor before starting treatment. Your doctor may recommend regular blood tests to monitor if Hormoclib 75mg Capsule is affecting your blood cell counts.

References

  1. Pfizer Limited, Electronic medicines compendium (emc), [Revised on June 2021] [ Accessed on 26 Nov 2022], https://www.medicines.org.uk/emc/files/pil.4449.pdf
  2. Pfizer Labs, US Food and Drug Administration, [Revised on March 2017] [ Accessed on 26 Nov 2022], https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/207103s004lbl.pdf
  3. Neha S Mangini et al; Palbociclib: A Novel Cyclin-Dependent Kinase Inhibitor for Hormone Receptor-Positive Advanced Breast Cancer; The Annals of Pharmacotherapy; Published on Nov 2015; Accessed on 26/11/2022; https://pubmed.ncbi.nlm.nih.gov/26324355/
  4. Palbace; Pfizer; Revised on Oct 2021; Accessed on 26/11/2022; https://labeling.pfizer.com/ShowLabeling.aspx?id=14029

Safety Advice

Pregnancy: unsafe It is not recommended to take Hormoclib 75mg Capsule during pregnancy as it can harm the unborn baby. Women with childbearing potential should use effective contraceptives during treatment and for at least three weeks after treatment.

Lungs: Consult your doctor It is not unknown whether Hormoclib 75mg Capsule can be administered to patients with lung problems. Consult your doctor if you have any lung diseases before starting the treatment.

Breastfeeding: unsafe Hormoclib It is not recommended to take Hormoclib 75mg Capsule while breastfeeding as it is not known whether it passes into the breast milk.

Disclaimer

The information provided on this page is intended for general informational purposes only and should not be considered as medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication. Self-medication can be harmful. Med For Rare does not endorse self-diagnosis or self-treatment.

Written By: Muskan Patel, M.Pharm

Reviewed By: Dr. Vishwa Patel, MBBS